Publicaciones en colaboración con investigadores/as de Clínica Universitaria de Navarra (26)

2024

  1. Systemic messenger RNA replacement therapy is effective in a novel clinically relevant model of acute intermittent porphyria developed in non-human primates

    Gut

2023

  1. A pharmacometrics model to define docetaxel target in early breast cancer

    British Journal of Clinical Pharmacology, Vol. 89, Núm. 2, pp. 727-736

2021

  1. Farmacocinética y farmacogenética en la optimización de los tratamientos en psiquiatría: Revisión sistemática

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 45, Núm. 7, pp. 84-93

2018

  1. Influence of comedication on levetiracetam pharmacokinetics

    Therapeutic Drug Monitoring, Vol. 40, Núm. 1, pp. 130-134

2014

  1. Monitoring of everolimus trough concentrations for achieving optimal tolerance in the management of tuberous sclerosis complex

    Pediatric Neurology

2010

  1. LC method for therapeutic drug monitoring of levetiracetam: Evaluation of the assay performance and validation of its application in the routine area

    Clinical Biochemistry, Vol. 43, Núm. 4-5, pp. 473-482

2009

  1. LC method for the therapeutic drug monitoring of lamotrigine: Evaluation of the assay performance and validation of its application in the routine area

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 49, Núm. 2, pp. 547-553

2007

  1. Phase I and Pharmacokinetic Study of Gemcitabine Administered at Fixed-Dose Rate, Combined with Docetaxel/Melphalan/Carboplatin, with Autologous Hematopoietic Progenitor-Cell Support, in Patients with Advanced Refractory Tumors

    Biology of Blood and Marrow Transplantation, Vol. 13, Núm. 11, pp. 1324-1337

2006

  1. Tegafur and 5-fluorouracil pelvic tissue concentrations in rectal cancer patients receiving preoperative chemoradiation

    Clinical and Translational Oncology, Vol. 8, Núm. 7, pp. 500-507

2004

  1. Methotrexate Pharmacokinetics and Survival in Osteosarcoma

    Pediatric Blood and Cancer, Vol. 42, Núm. 1, pp. 52-58

  2. Simple determination of capecitabine and its metabolites by liquid chromatography with ultraviolet detection in a single injection

    Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 809, Núm. 1, pp. 51-58

2003

  1. Determination of 5-fluorouracil and its prodrug tegafur in plasma and tissue by high-performance liquid chromatography in a single injection: Validation for application in clinical pharmacokinetic studies

    Therapeutic Drug Monitoring, Vol. 25, Núm. 2, pp. 221-228

  2. Información de medicamentos a la población desde el Servicio de Farmacia a través de Internet

    Farmacia Hospitalaria, Vol. 27, Núm. 6, pp. 353-359

2002

  1. Pharmacodynamics of high-dose methotrexate in pediatric patients

    Annals of Pharmacotherapy, Vol. 36, Núm. 9, pp. 1344-1350

  2. Predicción del retraso en la eliminación de metotrexato mediante métodos bayesianos

    Farmacia Hospitalaria, Vol. 26, Núm. 2, pp. 90-95

2001

  1. Separation methods for camptothecin and related compounds

    Journal of Chromatography B: Biomedical Sciences and Applications, Vol. 764, Núm. 1-2, pp. 141-159

  2. Simple and rapid determination of carboplatin in plasma by high-performance liquid chromatography. Error pattern and application to clinical pharmacokinetic studies

    Journal of Chromatography B: Biomedical Sciences and Applications, Vol. 764, Núm. 1-2, pp. 457-464

2000

  1. Effects of hepatic function on vancomycin pharmacokinetics in patients with cancer

    Therapeutic Drug Monitoring, Vol. 22, Núm. 3, pp. 250-257

  2. Simple and rapid determination of irinotecan and its metabolite SN-38 in plasma by high-performance liquid-chromatography: Application to clinical pharmacokinetic studies

    Journal of Chromatography B: Biomedical Sciences and Applications, Vol. 740, Núm. 2, pp. 159-168

1999

  1. Relationship between pharmacokinetic parameters of gentamicin and patient characteristics and/or clinical data in patients with solid organ turnouts

    Pharmacy World and Science, Vol. 21, Núm. 5, pp. 227-232